Bertolotti Syndrome in the Pediatric Population: A Literature Review and Management Algorithm

Daniel C Gabriel1, David S Liu, Bryan Ang

  • 1From the Harvard Medical School, Boston, MA (Gabriel, Hines, and Prabhat); the Lenox Hill Hospital, New York, NY (Dr. Ang); and the Boston Children's Hospital, Department of Orthopedic Surgery, Boston, MA (Dr. Liu and Dr. Hogue).

Insights

This study proposes a step-wise management algorithm for pediatric Bertolotti syndrome, guiding treatment from conservative options to surgery. All reviewed pediatric patients experienced symptom resolution, highlighting effective management strategies for this condition.

Area of Science:

  • Pediatric Orthopedics
  • Spine Surgery
  • Medical Algorithms

Background:

  • Bertolotti syndrome is a congenital anomaly with a spectrum of clinical presentations.
  • Management strategies for pediatric Bertolotti syndrome require a structured approach.

Purpose of the Study:

  • To develop a comprehensive, step-wise management algorithm for pediatric Bertolotti syndrome.
  • To systematically review diagnostic evaluation, treatment options, and outcomes for this condition in children.

Main Methods:

  • Systematic literature review using PubMed.
  • Inclusion of studies focusing on pediatric Bertolotti syndrome management.
  • Data extraction on clinical presentation, imaging, treatment, and outcomes.

Main Results:

  • 17 pediatric patients from 13 studies were analyzed.
  • Lower back and radicular pain were primary symptoms.
  • Treatments included conservative measures (physical therapy, NSAIDs, bracing, injections) and surgical options (resection, fusion).
  • All patients achieved symptom resolution.

Conclusions:

  • A stepwise management algorithm for pediatric Bertolotti syndrome is proposed.
  • Recommend a progression from conservative to surgical treatment based on symptom persistence.
  • The algorithm aims to optimize outcomes for pediatric patients.
Abstract

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
808
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
7.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
584
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214